Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

NCT01119313 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Eczema

Interventions

DRUG: LAS 41002
DRUG: Active

Sponsor

Almirall, S.A.